Rochester Medical FemSoft Incontinence Insert Among FY 1999's 33 PMAs
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of Rochester Medical's FemSoft insert for female stress urinary incontinence on Sept. 30, the final day of the federal government's fiscal year, apparently put the agency's total number of approved, original premarket approval applications for the year at 33, down from 42 in 1998 and 46 in 1997.
You may also be interested in...
Rare Bladder Disease Assay, Incontinence Treatment Urged
Discovery of a protein in the urine of interstitial cystitis (IC) sufferers may lead to development of a diagnostic for the disease, according to Vicki Ratner, MD, president of the Interstitial Cystitis Association
Rare Bladder Disease Assay, Incontinence Treatment Urged
Discovery of a protein in the urine of interstitial cystitis (IC) sufferers may lead to development of a diagnostic for the disease, according to Vicki Ratner, MD, president of the Interstitial Cystitis Association
Risk Classification Governs SUD Reprocessor Premarket Requirements - FDA
FDA's current resource levels are insufficient to carry out inspections of health care facilities that reprocess medical devices intended for single use, FDA staffers believe.